170 related articles for article (PubMed ID: 30630106)
1. Tetrahydropyridine derivative as efflux inhibitor in Mycobacterium abscessus.
Vianna JS; Ramis IB; Bierhals D; von Groll A; Ramos DF; Zanatta N; Lourenço MC; Viveiros M; Almeida da Silva PE
J Glob Antimicrob Resist; 2019 Jun; 17():296-299. PubMed ID: 30630106
[TBL] [Abstract][Full Text] [Related]
2. In silico and in vitro evaluation of tetrahydropyridine compounds as efflux inhibitors in Mycobacterium abscessus.
Ramis IB; Vianna JS; Silva Junior L; von Groll A; Ramos DF; Lobo MM; Zanatta N; Viveiros M; Silva PEAD
Tuberculosis (Edinb); 2019 Sep; 118():101853. PubMed ID: 31430699
[TBL] [Abstract][Full Text] [Related]
3. [Effects of four efflux pump inhibitors on the activities of clarithromycin against
Teng TL; Shang YY; Huang HR; Chu NH; Chen ST
Zhonghua Jie He He Hu Xi Za Zhi; 2022 May; 45(5):468-474. PubMed ID: 35527462
[No Abstract] [Full Text] [Related]
4. Targeting bedaquiline mycobacterial efflux pump to potentially enhance therapy in
Martin A; Bouyakoub Y; Soumillion K; Mantu EON; Colmant A; Rodriguez-Villalobos H
Int J Mycobacteriol; 2020; 9(1):71-75. PubMed ID: 32474492
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of tedizolid against the Mycobacterium abscessus complex.
Compain F; Soroka D; Heym B; Gaillard JL; Herrmann JL; Dorchène D; Arthur M; Dubée V
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):186-189. PubMed ID: 29217419
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
Lee MC; Sun PL; Wu TL; Wang LH; Yang CH; Chung WH; Kuo AJ; Liu TP; Lu JJ; Chiu CH; Lai HC; Chen NY; Yang JH; Wu TS
J Antimicrob Chemother; 2017 Oct; 72(10):2782-2786. PubMed ID: 29091186
[TBL] [Abstract][Full Text] [Related]
7.
Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
[TBL] [Abstract][Full Text] [Related]
8.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
[TBL] [Abstract][Full Text] [Related]
9. The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex.
Takei S; Ihara H; Togo S; Nakamura A; Fujimoto Y; Watanabe J; Kurokawa K; Shibayama K; Sumiyoshi I; Ochi Y; Iwai M; Okabe T; Chonan M; Misawa S; Ohsaka A; Takahashi K
BMC Microbiol; 2020 Oct; 20(1):316. PubMed ID: 33076820
[TBL] [Abstract][Full Text] [Related]
10. Efflux pump effects on levofloxacin resistance in
Teng T; Chen S; Huo F; Jia J; Zhao L; Jiang G; Wang F; Chu N; Huang H
Antimicrob Agents Chemother; 2024 May; 68(5):e0134823. PubMed ID: 38572960
[No Abstract] [Full Text] [Related]
11. Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies.
Mougari F; Bouziane F; Crockett F; Nessar R; Chau F; Veziris N; Sapriel G; Raskine L; Cambau E
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799212
[TBL] [Abstract][Full Text] [Related]
12. Rapid Detection of Clarithromycin and Amikacin Resistance in Mycobacterium abscessus Complex by High-Resolution Melting Curve Analysis.
Li H; Mulati G; Shang Y; Yao C; Wang Y; Ren W; Xue Z; Li S; Pang Y
Microbiol Spectr; 2022 Jun; 10(3):e0057422. PubMed ID: 35638787
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay.
Portell-Buj E; Bonet-Rossinyol Q; López-Gavín A; Roman A; Fernández-Pittol M; Tudó G; Gonzalez-Martin J
J Antibiot (Tokyo); 2021 Apr; 74(4):285-290. PubMed ID: 33420382
[TBL] [Abstract][Full Text] [Related]
14. Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps.
Mudde SE; Schildkraut JA; Ammerman NC; de Vogel CP; de Steenwinkel JEM; van Ingen J; Bax HI
J Glob Antimicrob Resist; 2022 Dec; 31():345-352. PubMed ID: 36347496
[TBL] [Abstract][Full Text] [Related]
15. Genetic Correlation of Antibiotic Susceptibility and Resistance Genotyping for the
Zheng H; Liu D; Lu J; Song Y; Wang S; Zhao Y; Ni X
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397054
[TBL] [Abstract][Full Text] [Related]
16. Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the
Pryjma M; Burian J; Kuchinski K; Thompson CJ
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874379
[TBL] [Abstract][Full Text] [Related]
17. Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents.
Yoshida S; Tsuyuguchi K; Suzuki K; Tomita M; Okada M; Hayashi S; Iwamoto T; Saito H
Int J Antimicrob Agents; 2013 Sep; 42(3):226-31. PubMed ID: 23850022
[TBL] [Abstract][Full Text] [Related]
18. Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex.
Rubio M; March F; Garrigó M; Moreno C; Español M; Coll P
PLoS One; 2015; 10(10):e0140166. PubMed ID: 26448181
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial and Efflux Inhibitor Activity of Usnic Acid Against Mycobacterium abscessus.
Ramis IB; Vianna JS; Reis AJ; von Groll A; Ramos DF; Viveiros M; da Silva PEA
Planta Med; 2018 Nov; 84(17):1265-1270. PubMed ID: 29913527
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach.
Liu Y; Tan Y; Islam MM; Cao Y; Lu X; Zeng S; Hameed HMA; Zhou P; Cai X; Wang S; Mugweru JN; Zhang G; Yin H; Liu J; Nuermberger E; Zhang T
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31843996
[No Abstract] [Full Text] [Related]
[Next] [New Search]
